Evidence map›Paper›PMID 28976812›Full record

ArticleRegenerative medicine2017

The European General Data Protection Regulation: challenges and considerations for iPSC researchers and biobanks.

Michael Morrison, Jessica Bell, Carol George, Shawn Harmon, Megan Munsie, Jane Kaye

Open access · hybridAbstract read
In one paragraph

Article in Regenerative medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
2.7field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 56 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Dwarna: a blockchain solution for dynamic consent in biobanking.European journal of human genetics : EJHG · 2020
    Article
  9. Review
  10. Review
  11. Informatics Approaches for Harmonized Intelligent Integration of Stem Cell Research.Stem cells and cloning : advances and applications · 2020
    Review
  12. Article
  13. Review
  14. Review
  15. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Michael MorrisonNuffield Department of Population Health, HeLEX - Center for Health, Law & Emerging Technologies, University of Oxford, Ewert House, Ewert Place, Banbury Road, Oxford OX2 7DD, UK.
Jessica BellNuffield Department of Population Health, HeLEX - Center for Health, Law & Emerging Technologies, University of Oxford, Ewert House, Ewert Place, Banbury Road, Oxford OX2 7DD, UK.
Carol GeorgeSchool of Law, Kenyon Mason Institute for Medicine, Life Sciences & Law, University of Edinburgh, Old College, South Bridge, Edinburgh EH8 9YL, UK.
Shawn HarmonSchool of Law, Kenyon Mason Institute for Medicine, Life Sciences & Law, University of Edinburgh, Old College, South Bridge, Edinburgh EH8 9YL, UK.
Megan MunsieDepartment of Anatomy & Neuroscience, Stem Cells Center for Stem Cell Systems, University of Melbourne, Parkville, VIC 3010, Australia.
Jane KayeNuffield Department of Population Health, HeLEX - Center for Health, Law & Emerging Technologies, University of Oxford, Ewert House, Ewert Place, Banbury Road, Oxford OX2 7DD, UK.
Edinburgh College · GBUniversity of Melbourne · AUStem Cells Australia · AUUniversity of Oxford · GB

Funding

Wellcome TrustWellcome Trust 096599/2/11/Z
6 · The paper itself

Abstract

Increasingly, human induced pluripotent stem cells (iPSC) and their associated genetic and clinical information are being used in a wide range of applications, with large biobanks being established to support and increase their scientific use. The new European General Data Protection Regulations, which comes into effect in 2018, will have implications for biobanks that generate, store and allow research access to iPSC. This paper describes some of the challenges that iPSC biobanks face and suggests some points for the development of appropriate governance structures to address these new requirements. These suggestions also have implications for iPSC research in general.

Indexed as

Induced Pluripotent Stem CellsSocial Control, FormalBiological Specimen BanksComputer SecurityEuropeHumansInformed Consentbiobanksdata protectiongovernanceinduced pluripotent stem cellsstem cells

Identifiers

PMID28976812
PMCPMC5857917
OpenAlexW2763965253

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.